Washington University in St. Louis

Mission Statement

The ICTS accelerates clinical and translational research to improve health outcomes and benefit the well-being of our communities.

At a Glance

2

Educational Resources Posted

75

Consortium News Stories Posted

3

Events Posted

0

Opportunities Posted

85

Publications citing CTSA Program Grant

36

Users from Hub Registered
Contact PI Organization
Programs

UL1 Award

KL2 Award

TL1 Award

Funded Years
2012 - 2021
Connect with Us

Consortium News

The ICTS has awarded four separate awards to investigators in the ICTS’ first-ever virtual poster display and contest. As part of the 4th annual ICTS Symposium, 47 separate posters were submitted and reviewed by 22 ICTS faculty from Washington University in St. Louis, University of Missouri – Columbia, and Saint Louis University. Posters showcased ICTS-supported research and were categorized by

The Washington University Institute of Clinical and Translational Sciences (ICTS) hosted their 4th annual Symposium and Poster Display on Friday, May 13, 2022. The theme “Making an Impact, Shaping the Future” focused on strategies to address equity and diversity challenges experienced by institutions across the national Clinical and Translational Science Awards (CTSA) network. The hybrid event

Washington University School of Medicine in St. Louis has received a $61 million grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) to support the infrastructure for developing and carrying out biomedical research studies. The funding supports Washington University’s Institute of Clinical and Translational Sciences (ICTS), which was

Educational Content

Washington University

Washington University in St. Louis is recruiting for the fall program of our NIH-funded Entrepreneurship for Biomedicine (E4B) training program. E4B is free and taught fully online through Washington University in St. Louis. As an E4B trainee, you will work with biomedical research trainees from across the nation to innovatively solve problems in these challenging times, and develop skills in

Washington University
Dissemination and Implementation (D&I) science is the study of translation of research findings into practice. Eight pdf files: DIRC Intro to D&I Toolkit, Aims Toolkit, Barriers & Facilitators Toolkit, Implementation Outcomes Toolkit, Designs Toolkit, Implementation Strategies Toolkit, Guidelines Toolkit, Checklist for Writing IR Proposals DIRC Aims Toolkit DIRC Barriers & Facilitators Toolkit
4th Annual Washington University ICTS Symposium and Poster Display
-
Washington University

“Making an Impact, Shaping the Future” Please join us for the 4th annual symposium hosted by the Washington University Institute of Clinical and Translational Sciences. This year’s theme focuses on strategies to address equity and diversity challenges experienced by institutions across the national CTSA network. This is a hybrid event with opportunities to attend virtually or in-person. May 13

Washington University in St. Louis
-
Washington University

The CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will

Washington University in St. Louis School of Medicine
-
Washington University
KL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Cicely W. Fadel, MD, PhD from Harvard Medical School, hosted by Washington University in St. Louis will present her research on Gut Interrupted: Modeling Microbiome-Dependent Modulation of Premature Infant Intestinal Vulnerability

Poster Sessions

Washington University

Introduction: The STOP COVID Trials were innovative fully-remote randomized controlled trials of fluvoxamine (a sigma1 receptor agonist with anti-inflammatory properties) vs placebo for treatment of outpatients with early COVID-19 who were self-isolating at home. Methods: The trials used eConsent and an electronic data capture system with integrated recruitment from the EPIC electronic health

Washington University

As a result of the CTSA Program’s objective to strengthen multidisciplinary research infrastructure, hubs are uniquely poised to mobilize their vast resources to produce a rapid, nimble, multi-faceted approach to national public health emergencies. The Institute of Clinical and Translational Sciences, the CTSA grantee at Washington University in St. Louis, is a critical contributor to the

Washington University Poster
Washington University

The goal of the Precision Medicine function of the Washington University Institute of Clinical and Translational Sciences is to streamline precision medicine research processes across the university. Three separate initiatives supported this effort: (1) outreach to community and faculty members through surveys and focus groups to assess interest and concerns regarding participation in precision

Publications

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of

The safety of hepatectomy after transarterial radioembolization: Single institution experience and review of the literature

The liver is a frequent site of malignancy, both primary and metastatic. The treatment goal of patients with liver cancer may include transarterial radioembolization (TARE). There are limited reports on the safety of hepatectomy following TARE. Our study's purpose is to review patients who have

Eating disorder symptomatology, clinical impairment, and comorbid psychopathology in racially and ethnically diverse college women with eating disorders

To examine eating disorder (ED) symptomatology, related clinical impairment, and comorbid psychopathology in college women with EDs across five racial and two ethnic groups. Participants were 690 women from 28 US universities who screened positive for an ED. Thirteen variables assessing ED symptoms

Research and Operational Tools

Washington University

The Translational Science Benefits Model (TSBM) is a framework designed to support institutional assessment of clinical and translational research outcomes to measure clinical and community health impacts beyond bibliometric measures.

Title Authored Sort ascending Content type
Washington University ICTS awards winning entries in first-ever virtual poster display May 20, 2022 Consortium News
Washington University ICTS holds 4th annual Symposium May 20, 2022 Consortium News
Washington University Institute of Clinical and Translational Sciences Receives $61 Million in Funding May 18, 2022 Consortium News
The Washington University ICTS TL1 Program: Training the Future Clinical and Translational Workforce March 30, 2022 Consortium News
Washington University ICTS Announces 2022-2023 CTRFP Awardees March 30, 2022 Consortium News
4th Annual Washington University ICTS Symposium and Poster Display March 30, 2022 Event
Washington University ICTS Director William Powderly, MD, moderates discussion with CDC Director Rochelle Walensky, MD, MPH March 08, 2022 Consortium News
Washington University ICTS investigator advances research into noise-induced hearing loss March 07, 2022 Consortium News
CTSA Visiting Scholar Program - Janet Alexander, MD March 01, 2022 Event
UF leads team ready to tackle vaccine skepticism in Florida and beyond January 12, 2022 Consortium News
What makes an mRNA vaccine so effective against severe COVID-19? January 11, 2022 Consortium News
ICTS Community Advisory Board co-chair featured in People Magazine regarding rare disease journey January 11, 2022 Consortium News
Washington University ICTS Team Wins Inaugural TL1 Debate, ‘Statin Wars’ December 13, 2021 Consortium News
Coming up with a COVID (cure?): Using e-consent and national recruitment in a fully-remote clinical trial November 04, 2021 Poster
Washington University ICTS Core Provides Foundation for Unprecedented Pediatric COVID Collaboration October 28, 2021 Consortium News
What good is discovery if you can’t share it? October 22, 2021 Consortium News
COVID-19 transmission at school rare for children with disabilities September 13, 2021 Consortium News
Study supported by Washington University ICTS shows COVID-19 vaccine elicits antibodies in 90% taking immunosuppressants September 13, 2021 Consortium News
Washington University ICTS supports research featured in NIH Director’s blog September 13, 2021 Consortium News
Washington University ICTS investigators in the field of Dissemination and Implementation ask: How can we use what we already know to make people healthier? August 20, 2021 Consortium News
ICTS Associate Director Christina Gurnett, MD, PhD featured speaker at the NextGen Precision Health Discovery Series. August 20, 2021 Consortium News
Research supported by Washington University ICTS finds that antibodies elicited by COVID-19 vaccination effective against delta variant August 17, 2021 Consortium News
Investigator uses Washington University ICTS resources for COVID-19 research and clinical trial efforts July 22, 2021 Consortium News
CTSA Visiting Scholar Program: Gut Interrupted: Modeling Microbiome-Dependent Modulation of Premature Infant Intestinal Vulnerability July 15, 2021 Event
Washington University ICTS supports study that finds COVID-19 vaccine generates immune structures critical for lasting immunity June 29, 2021 Consortium News
If you build it, will they come? Linking researcher engagement and scientific productivity in large infrastructure grants June 28, 2021 Consortium News
Measuring the impact of science; How CTSAs use the Translational Science Benefits Model to show real world benefits June 28, 2021 Consortium News
Washington University ICTS Partnership Development and Sustainability Support Program (PDSS) Awardees Announced June 16, 2021 Consortium News
Washington University ICTS supports new study that suggests, among men, low testosterone levels in the blood are linked to more severe COVID-19 June 16, 2021 Consortium News
Washington University ICTS supports research showing that people who have had a mild case of COVID-19 are left with long-term antibody protection against future disease June 16, 2021 Consortium News
Washington University School of Medicine in St. Louis joins All of Us Research Program with support from the ICTS May 18, 2021 Consortium News
Washington University ICTS helps fund study showing how COVID-19 increases risk of pregnancy complications May 07, 2021 Consortium News
New study funded by Washington University Institute of Clinical and Translational Sciences shows that for breastfeeding moms, COVID-19 vaccinations may also protect babies April 07, 2021 Consortium News
Washington University ICTS investigators find opioid overdose reduced in patients taking buprenorphine March 11, 2021 Consortium News
Washington University ICTS investigators find new evidence COVID-19 antibodies, vaccines less effective against variants March 11, 2021 Consortium News
Washington University ICTS provides framework for unique community collaboration to develop and thrive March 11, 2021 Consortium News
Washington University ICTS investigators find promising role for whole genome sequencing in guiding blood cancer treatment March 11, 2021 Consortium News
Saint Louis University ICTS investigator utilizes funding mechanism to advance research on opioid therapy options March 09, 2021 Consortium News
Washington University Institute of Clinical and Translational Sciences (ICTS) awards 17 investigators as part of the 14th annual Clinical and Translational Research Funding Program (CTRFP) February 26, 2021 Consortium News
COVID-19 vaccines at Washington University School of Medicine February 22, 2021 Consortium News
Washington University ICTS investigators test fluvoxamine repurposed as treatment for COVID, Utilize fully-remote clinical trial to reach participants February 12, 2021 Consortium News
Rapid blood test identifies COVID-19 patients at high risk of severe disease February 12, 2021 Consortium News
Podcast: Washington University ICTS investigators research fluvoxamine repurposed for COVID-19 patients. National, multicenter, fully remote trial underway. January 13, 2021 Consortium News
Washington University ICTS Director welcomes Dr. Anthony Fauci as Gerald Medoff Visiting Professor on January 7 January 13, 2021 Consortium News
Washington University ICTS Researchers Find Fluvoxamine May Prevent Serious Illness in COVID-19 Patients December 18, 2020 Consortium News
Washington University ICTS Community Advisory Board to provide ongoing advice on grant funded by the NIH 's Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) initiative December 18, 2020 Consortium News
KL2 Alumnus Maximizes Washington University ICTS Options to Gain Skills for Dual Career as Researcher and ICU Clinician December 16, 2020 Consortium News
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm November 18, 2020 Consortium News
Washington University ICTS partner institutions Saint Louis University and Washington University work together to recruit St. Louis residents for trials part of CoVPN November 18, 2020 Consortium News
Doug Lindsay, Washington University ICTS Community Advisory Board Co-chair, appointed to PCORI's Rare Disease Advisory Panel November 04, 2020 Consortium News